CAR-T cell therapy is a promising treatment for multiple myeloma, especially for those with advanced or hard-to-treat cases. Here are some key points from my knowledge base:

- Effectiveness: In clinical trials, 2 out of 3 participants were in remission for at least one year
- Side Effects: Common side effects include Show Full Answer

CAR-T cell therapy is a promising treatment for multiple myeloma, especially for those with advanced or hard-to-treat cases. Here are some key points from my knowledge base:

- Effectiveness: In clinical trials, 2 out of 3 participants were in remission for at least one year.
- Side Effects: Common side effects include infections, muscle aches, diarrhea, nausea, swelling, fever, cough, headache, and loss of appetite. Most side effects are mild, but serious ones can occur.
- Process: T cells are collected, genetically modified, and then returned to the body to target and kill cancer cells.
- Hospital Stay: Patients often need to stay in the hospital for several weeks post-infusion to monitor for complications.

It's important to discuss the risks and benefits with your doctor to make an informed decision.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam

Immunotherapy for Multiple Myeloma: What To Know | MyMyelomaTeam